In pancreatic cancer, frequent mutations occur in driver genes such as KRAS (88%), TP53 (77%), SMAD4 (29%), CDKN2A (18%) and TGFBR2 (7%) [7,8]. Here, KRAS is linked to pancreatic neoplasm.